Last updated: 1 July 2024 at 4:15pm EST

Scott Ullem Net Worth




The estimated Net Worth of Scott B. Ullem is at least $5.99 Million dollars as of 20 June 2024. Mr. Ullem owns over 5,625 units of Edwards Lifesciences Corp stock worth over $2,417,587 and over the last 11 years he sold EW stock worth over $0. In addition, he makes $3,571,070 as Chief Financial Officer and Corporate Vice President at Edwards Lifesciences Corp.

Mr. Ullem EW stock SEC Form 4 insiders trading

Scott has made over 44 trades of the Edwards Lifesciences Corp stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 5,625 units of EW stock worth $254,700 on 20 June 2024.

The largest trade he's ever made was exercising 80,700 units of Edwards Lifesciences Corp stock on 10 May 2023 worth over $2,840,640. On average, Scott trades about 8,080 units every 30 days since 2014. As of 20 June 2024 he still owns at least 36,186 units of Edwards Lifesciences Corp stock.

You can see the complete history of Mr. Ullem stock trades at the bottom of the page.





Scott Ullem biography

Scott B. Ullem serves as Chief Financial Officer, Corporate Vice President of the Company. Mr. Ullem became Corporate Vice President, Chief Financial Officer in January 2014. In addition, Mr. Ullem has executive responsibility for the Company’s information technology, information security and corporate services teams. Prior to joining Edwards, he served from May 2010 to December 2013 as Chief Financial Officer of Bemis Company Inc., a Fortune 500 publicly traded global supplier of packaging and pressure sensitive materials used in leading food, consumer, and healthcare products. Mr. Ullem also had leadership responsibility for one of Bemis’ three business segments and the company’s information technology function. Before joining Bemis, Mr. Ullem spent 17 years in investment banking, serving as Managing Director at Goldman Sachs and later at Bank of America. He has served on the Board and Compensation Committee of Berry Global Inc. since 2016 and is a Henry Crown Fellow at the Aspen Institute

What is the salary of Scott Ullem?

As the Chief Financial Officer and Corporate Vice President of Edwards Lifesciences Corp, the total compensation of Scott Ullem at Edwards Lifesciences Corp is $3,571,070. There are 1 executives at Edwards Lifesciences Corp getting paid more, with Michael Mussallem having the highest compensation of $11,521,000.



How old is Scott Ullem?

Scott Ullem is 53, he's been the Chief Financial Officer and Corporate Vice President of Edwards Lifesciences Corp since 2014. There are 20 older and 1 younger executives at Edwards Lifesciences Corp. The oldest executive at Edwards Lifesciences Corp is William Link, 74, who is the Independent Director.

What's Scott Ullem's mailing address?

Scott's mailing address filed with the SEC is 5200 ILLUMINA WAY, , SAN DIEGO, CA, 92122.

Insiders trading at Edwards Lifesciences Corp

Over the last 22 years, insiders at Edwards Lifesciences Corp have traded over $94,964,396 worth of Edwards Lifesciences Corp stock and bought 47,398 units worth $3,992,090 . The most active insiders traders include Michael A Mussallem, Donald E Jr Bobo, and Steven R Loranger. On average, Edwards Lifesciences Corp executives and independent directors trade stock every 8 days with the average trade being worth of $1,126,057. The most recent stock trade was executed by Donald E Jr Bobo on 11 September 2024, trading 5,000 units of EW stock currently worth $226,400.



What does Edwards Lifesciences Corp do?

edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.



Complete history of Mr. Ullem stock trades at Illumina Inc, Berry Global Inc, and Edwards Lifesciences Corp

Insider
Trans.
Transaction
Total value
Scott B. Ullem
CVP and Chief Financial Officer
Option $254,700
20 Jun 2024
Scott B. Ullem
CVP and Chief Financial Officer
Option $254,700
21 May 2024
Scott B. Ullem
CVP and Chief Financial Officer
Option $636,391
3 May 2024
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,438
30 Apr 2024
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
1 Apr 2024
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
29 Feb 2024
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
1 Feb 2024
Scott B. Ullem
CVP and Chief Financial Officer
Option $533,243
29 Dec 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
31 Oct 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
29 Sep 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
31 Aug 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
31 Jul 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $266,621
30 Jun 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $2,840,640
10 May 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $537,942
7 May 2023
Scott B. Ullem
CVP and Chief Financial Officer
Option $1,490,812
7 May 2022
Scott B. Ullem
CVP and Chief Financial Officer
Option $1,544,791
17 May 2021
Scott B. Ullem
CVP and Chief Financial Officer
Option $721,344
26 Oct 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $721,344
12 Oct 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $721,344
28 Sep 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $721,344
15 Sep 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $373,266
14 Sep 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $373,266
6 Aug 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $373,266
6 Jul 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $373,266
22 Jun 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $1,486,680
11 May 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $314,550
7 Jan 2020
Scott B. Ullem
CVP and Chief Financial Officer
Option $314,550
10 Dec 2019
Scott B. Ullem
CVP and Chief Financial Officer
Option $314,550
12 Nov 2019
Scott B. Ullem
CVP and Chief Financial Officer
Option $314,550
29 Oct 2019
Scott B. Ullem
CVP and Chief Financial Officer
Option $314,550
9 Sep 2019
Scott B. Ullem
CVP and Chief Financial Officer
Option $314,550
26 Aug 2019
Scott B. Ullem
CVP and Chief Financial Officer
Option $504,182
12 May 2019
Scott B. Ullem
CVP and Chief Financial Officer
Option $852,476
5 Sep 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $851,250
15 Aug 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $851,250
3 Jul 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $851,250
6 Jun 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $1,324,911
16 May 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $851,250
9 May 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $851,250
4 Apr 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $851,250
28 Mar 2018
Scott B. Ullem
CVP and Chief Financial Officer
Option $1,161,405
10 May 2017
Scott B. Ullem
Option $127,341
25 Nov 2023
Scott B. Ullem
Option $180,980
23 Nov 2021


Edwards Lifesciences Corp executives and stock owners

Edwards Lifesciences Corp executives and other stock owners filed with the SEC include: